BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
Ricin News and Headlines
Ricin news updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Ricin news alerts.
Site Map > Biotechnology News > Health News > Ricin
.

Double-Stranded RNA-Activated Protein Kinase (PKR) Mediates Induction of IL-8 Expression by Deoxynivalenol, Sh
Toxicological Sciences:  similar ...
DOR BioPharma Announces Collaboration With Numoda Corporation for the Execution of Confirmatory, Phase 3 Clini
Houston Chronicle:  similar ...
Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardio
Clinical Lab Products:  similar ...
Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardio
Biz Journals:  similar ...
Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardio
Nashville Business Journal:  similar ...
Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardio
Portland Business Journal:  similar ...
Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardio
Atlanta Business Chronicle:  similar ...
Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardio
The Business Journal Phoenix:  similar ...
Universal Detection Technology Receives Repeat Order for Bio-Detection Kits by Leading Retailer of Athletic Ap
NewsBlaze:  similar ...
Comparative Induction of 28S Ribosomal RNA Cleavage by Ricin and the Trichothecenes Deoxynivalenol and T-2 Tox
Toxicological Sciences:  similar ...
DOR BioPharma Reports 1st Quarter 2008 Financial Results
Pharma Live:  similar ...
DOR BioPharma Acquires Option for Third-Generation Anthrax Vaccine from Harvard University
Pharma Live:  similar ...
DOR BioPharma Acquires Option for Third-Generation Anthrax Vaccine From Harvard University
Stockwatch:  similar ...
Dor BioPharma starts non-human efficacy studies for RiVax
Pharmaceutical Business Review:  similar ...
DOR BioPharma Initiates Non-Human Primate Efficacy Studies of Vaccine Against Ricin Toxin
Pharma Live:  similar ...
Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
PharmCast:  similar ...
DOR BioPharma Announces Successful Completion of cGMP Production Milestone for RiVax
Bioterrorism Week via NewsRx.com:  similar ...
DOR BioPharma, Inc. Announces 3 Month Extension of FDA PDUFA Action Date for orBec(R) New Drug Application to Review Supplemental Data
Market Wire, Incorporated:  similar ...
DOR BioPharma, Inc. Announces Initiation of orBec(R) Phase 2 GVHD Prophylaxis Clinical Trial
Market Wire, Incorporated:  similar ...
www.streetinvesting.com: Progressive Review for DOR BioPharma Inc. Against the Global Market
M2 Communications Ltd.:  similar ...

Search BioNews

      --- Advanced searching ---

 

Search BioWeb

      --- Advanced searching ---

 

BioPortfolio updates this list every 30 minutes so please bookmark and revisit regularly during the day:

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.